Translation of MPO-sensing MRI agent to visualize inflammatory disease activity in multiple sclerosis

Active Project Grant Awarded

Award ID
HT9425261E411
Recipient
Awarding agency
Obligated
$3,499,999

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date 8% complete
Place of performance
Leipsic, DE 19901, USA

Award details come from USAspending.gov.

About this award

The Defense Health Agency awarded Einsenca Inc. a Project Grant on July 29, 2026, obligating $3.499999 million under the Military Medical Research and Development program (Assistance Listing 12.420), with ultimate completion on August 31, 2030. The award funds translation of an MPO-sensing MRI agent to visualize inflammatory disease activity in multiple sclerosis. Work is performed at Leipsic, DE 19901, USA. The program supports basic, applied, and advanced biomedical research to transform health care for Service Members and the American public.

Quick answers

Who received award HT9425261E411?

HT9425261E411 was awarded to Einsenca Inc. by Defense Health Agency (Department of Defense) on July 29, 2026.

How much is award HT9425261E411 worth?

$3,499,999 has been obligated on HT9425261E411.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award